Passion for Dermatology
Bayer’s Dermatology unit is dedicated to provide innovative solutions for skin diseases. The global specialist has a successful track record in the development, manufacturing and marketing of innovative prescription drug products for the treatment of severe skin diseases.
Dermatology was also a pioneer in the development of locally applicable corticosteroid treatments.
As part of Bayer HealthCare with commercial operations all around the globe, the unit offers a broad spectrum of proven, top-quality products to treat acne, rosacea, eczema, psoriasis, hemorrhoids and fungal infections.
In 2010 - with more than 700 employees worldwide – Bayer’s Dermatology unit reached sales of €300 million. It is headed by CEO and President Marc Lafeuille and headquartered in Berlin with its main production facility in Milan, Italy.
| Headquarters | Berlin, Germany |
| Staff (2010) | About 700 |
| Sales (2010) | 306 € Mill. |
| Key countries | Austria, Brazil, France, Germany, Italy, Japan, Mexico, Poland, Portugal, Russia, Spain, Turkey, USA |
| President & Global Head of Dermatology | Marc Lafeuille |
| Finance & Administration | Dr. Alexander Henrici |
| Commercial Operations | Dr. Bernhard Schefter |
| Law & Patents | Ulf Zimmerling |
| Global Development | Dr. Eugene O'Keefe |
| Business Development | Dr. Lilian Vakalopoulou |
| Global Strategic Marketing | Daniela Chuayre Della Valle |
| Corporate Human Resources | Quilco Hasemann |
| Corporate Communications | Yvonne Moeller |